• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Maryland's Bonds Rated 'AAA'; Outlook Stable Jul 00

  • ID: 1886919
  • July 2000
  • Region: Maryland
  • Standard & Poors

WASHINGTON, D.C. (Standard & Poor's CreditWire) July 17, 2000-- Standard & Poor's today assigned its triple-'A' rating to Maryland's $200 million GO state and local facilities loan bonds series 2000 due Aug. 1, 2015. The bonds are scheduled to sell July 19, 2000. The outlook is stable. In addition, Standard & Poor's affirmed its triple-'A' rating on the state's $3.46 billion GO bonds. The rating reflects the state's: -- Broad-based economy, which continues to experience steady growth; -- High wealth and income levels; -- Historically strong financial performance and position; and -- Manageable debt burden enhanced by rapid debt maturities. Maryland's economic base is substantial and diverse, benefiting from a mature infrastructure and a well-educated and productive labor force. The...

Companies mentioned in this report are:
- Maryland

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown


Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.